Acting Attorney General Todd Blanche said on Aug. 4 that the Department of Justice (DOJ) is working with federal health agencies to prevent mail-order abortion pills from reaching states where the procedure is banned. Blanche made the remarks during a private conference call with faith leaders hosted by the White House Faith Office on July 30, according to recordings later posted online by the Christian group Intercessors for America.
Blanche stated that the administration is pursuing policies to make the 2022 Supreme Court Dobbs decision permanent in every state, emphasizing efforts to stop medication abortion drugs such as mifepristone from being distributed across state lines. The DOJ later clarified that Blanche’s comments were not a call for federal control over state abortion laws but a response to interstate distribution of abortion pills.
Key Developments
- Aug. 4: DOJ clarifies Blanche’s remarks after media reports, stating the focus is on preventing mail-order abortion pills from entering states with bans.
- July 30: Blanche tells faith leaders the administration is working to enforce the Dobbs decision nationwide through federal policies.
Federal Policy and Legal Context
The 2022 Dobbs v. Jackson Women’s Health Organization ruling overturned Roe v. Wade, returning abortion regulation authority to states. Since then, 14 states have banned abortion entirely, while others have implemented restrictions. However, shield laws in states where abortion remains legal—such as California, New York, and Massachusetts—have allowed clinicians to prescribe abortion pills via mail, enabling patients in restricted states to access medication abortion.
Blanche’s comments reflect an effort to address this discrepancy by targeting interstate distribution. The DOJ is coordinating with the Department of Health and Human Services (HHS), the Food and Drug Administration (FDA), and the White House to implement enforcement measures. The administration has not specified the exact policies but indicated they would be introduced “soon.”
Opposing Perspectives on Enforcement
Pro-life advocacy groups have welcomed Blanche’s remarks as a necessary step to uphold state-level abortion bans. For example, Susan B. Anthony Pro-Life America stated that preventing mail-order abortion pills from bypassing state laws is essential to protecting fetal life. “States have spoken through their laws, and the federal government must respect those decisions,” a spokesperson said.
Conversely, reproductive rights organizations argue that Blanche’s pledge represents an overreach of federal authority. Planned Parenthood and the Center for Reproductive Rights contend that the DOJ’s focus on interstate abortion pill distribution could infringe on the rights of patients in states where abortion is legal. “This is a direct attack on medical care and patient autonomy,” said a Planned Parenthood spokesperson. “Medication abortion is safe and legal in many states, and restricting access across state lines sets a dangerous precedent.”
Background: Medication Abortion and Interstate Distribution
Medication abortion, which accounts for over half of all abortions in the U.S., relies on two drugs: mifepristone and misoprostol. In 2023, the Biden administration removed the requirement that mifepristone be dispensed in person, allowing patients to receive the drug via mail after a telehealth consultation. This change, combined with shield laws in progressive states, has enabled patients in restrictive states to obtain abortion pills despite local bans.
Blanche’s pledge suggests the Trump administration is seeking to reverse this trend by targeting the interstate distribution of abortion medications. Legal experts note that such enforcement could face challenges, as the Comstock Act—a 19th-century law often cited in anti-abortion arguments—has been interpreted by some as prohibiting the mailing of abortion pills. However, the DOJ has not confirmed whether it plans to rely on this law for enforcement.
Timeline of Key Events
- June 24, 2022: Supreme Court overturns Roe v. Wade in Dobbs decision.
- 2023: Biden administration removes in-person dispensing requirement for mifepristone.
- July 30, 2024: Blanche outlines DOJ’s plans to enforce Dobbs decision nationwide during private call.
- Aug. 4, 2024: DOJ clarifies Blanche’s remarks, emphasizing focus on mail-order abortion pills.